Aziridine-2,3-dicarboxylate inhibitors targeting the major cysteine protease of Trypanosoma brucei as lead trypanocidal agents

Bioorganic & Medicinal Chemistry Letters
Radim VicikTanja Schirmeister

Abstract

The protozoan parasite Trypanosoma brucei causes Human African trypanosomiasis, which is fatal if left untreated. Due to the toxicity of currently used drugs and emerging drug resistance, there is an urgent need for novel therapies. The major trypanosome papain-like cysteine protease expressed by the parasite (e.g., rhodesain in T. b. rhodesiense) is considered an important target for the development of new trypanocidal drugs. Series of aziridine-2,3-dicarboxylate-based cysteine protease inhibitors have been tested, most of them inhibiting rhodesain in the low micromolar range. Among these, only dibenzyl aziridine-2,3-dicarboxylates display trypanocidal activity being equipotent to the drug eflornithine. The Leu-Pro-containing aziridinyl tripeptides 13a-f are the most promising as they are not cytotoxic to macrophages up to concentrations of 125microM.

Citations

Jan 12, 2011·Marine Biotechnology·Paula TabaresUte Hentschel
Jul 5, 2008·Journal of Chemical Information and Modeling·Mary Pat BeaversAmos B Smith
Apr 25, 2013·Journal of Medicinal Chemistry·Roberta EttariPaola Conti
Dec 2, 2011·Journal of Natural Products·Tyler A JohnsonPhillip Crews
Jul 22, 2009·The Journal of Biological Chemistry·Iain D KerrLinda S Brinen
Jun 28, 2006·Antimicrobial Agents and Chemotherapy·Alicia Ponte-SucreHeidrun Moll
Jan 27, 2009·Infection and Immunity·Nicolas Antoine-MoussiauxDaniel Desmecht
Nov 11, 2011·Marine Drugs·Sheila M Pimentel-ElardoUte Hentschel
Oct 23, 2013·Future Medicinal Chemistry·Lori FerrinsJonathan B Baell
Nov 18, 2015·Journal of Enzyme Inhibition and Medicinal Chemistry·Roberta EttariMaria Zappalà
Apr 4, 2012·Journal of Enzyme Inhibition and Medicinal Chemistry·Diego Magno AssisMaria Aparecida Juliano
Aug 19, 2016·Parasitology Research·Dietmar SteverdingDamião Pergentino de Sousa
May 5, 2009·Molecular and Biochemical Parasitology·Conor R Caffrey, Dietmar Steverding
Nov 19, 2013·ChemMedChem·Roberta EttariPaola Conti
Aug 31, 2006·Current Opinion in Infectious Diseases·Reto Brun, Oliver Balmer
Jun 15, 2007·ChemMedChem·Franziska SchulzTanja Schirmeister
May 3, 2008·Organic & Biomolecular Chemistry·Mie Højer VilhelmsenSteen Hammerum
Jun 20, 2012·Chemistry : a European Journal·Celso AlmeidaGabriele M König
Dec 18, 2019·Antimicrobial Agents and Chemotherapy·Natalie WiedemarPascal Mäser
Mar 27, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Philipp KleinTanja Schirmeister
Jun 26, 2013·Acta Crystallographica. Section E, Structure Reports Online·V GaumetV P Zaitsev
Dec 19, 2018·Pharmaceutical Research·Helen W HernandezSean Ekins
Feb 6, 2010·Journal of Medicinal Chemistry·Alexander BreuningTanja Schirmeister
Apr 14, 2010·Chemical Reviews·Wendy A LoughlinDavid P Fairlie
Oct 15, 2014·Journal of Natural Products·Sylvian CrettonPhilippe Christen
Aug 23, 2021·Bioorganic & Medicinal Chemistry·Wagner A S JudiceTiago Rodrigues
Oct 2, 2021·ChemMedChem·Michał G NowakMaria J Milewska

❮ Previous
Next ❯

Related Concepts

Related Feeds

African Trypanosomiasis

African trypanosomiasis, also known as sleeping sickness, is an insect-borne parasitic disease of humans and other animals. It is caused by protozoa of the species Trypanosoma brucei and almost invariably progresses to death unless treated. Discover the latest research on African trypanosomiasis here.